ID   SAMD8_HUMAN             Reviewed;         415 AA.
AC   Q96LT4; Q5JSC5; Q5JSC8; Q66K52;
DT   01-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   18-JUN-2025, entry version 175.
DE   RecName: Full=Sphingomyelin synthase-related protein 1 {ECO:0000305};
DE            Short=SMSr;
DE            EC=2.7.8.- {ECO:0000269|PubMed:19506037};
DE   AltName: Full=Ceramide phosphoethanolamine synthase;
DE            Short=CPE synthase;
DE   AltName: Full=Sterile alpha motif domain-containing protein 8;
DE            Short=SAM domain-containing protein 8;
GN   Name=SAMD8 {ECO:0000312|HGNC:HGNC:26320};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:BAB71586.1};
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Huitema K.;
RL   Submitted (FEB-2003) to UniProtKB.
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cerebellum {ECO:0000312|EMBL:BAB71586.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 198-359 (ISOFORM 1).
RA   Ebert L., Heil O., Hennig S., Neubert P., Partsch E., Peters M.,
RA   Radelof U., Schneider D., Korn B.;
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000305}
RP   IDENTIFICATION.
RX   PubMed=14685263; DOI=10.1038/sj.emboj.7600034;
RA   Huitema K., Van Den Dikkenberg J., Brouwers J.F.H.M., Holthuis J.C.;
RT   "Identification of a family of animal sphingomyelin synthases.";
RL   EMBO J. 23:33-44(2004).
RN   [8]
RP   SUBSTRATE SPECIFICITY, SUBCELLULAR LOCATION, FUNCTION, MUTAGENESIS OF
RP   ASP-348, IDENTIFICATION BY MASS SPECTROMETRY, AND CATALYTIC ACTIVITY.
RX   PubMed=19506037; DOI=10.1083/jcb.200903152;
RA   Vacaru A.M., Tafesse F.G., Ternes P., Kondylis V., Hermansson M.,
RA   Brouwers J.F., Somerharju P., Rabouille C., Holthuis J.C.;
RT   "Sphingomyelin synthase-related protein SMSr controls ceramide homeostasis
RT   in the ER.";
RL   J. Cell Biol. 185:1013-1027(2009).
RN   [9]
RP   FUNCTION.
RX   PubMed=33621517; DOI=10.1016/j.jbc.2021.100454;
RA   Murakami C., Sakane F.;
RT   "Sphingomyelin synthase-related protein generates diacylglycerol via the
RT   hydrolysis of glycerophospholipids in the absence of ceramide.";
RL   J. Biol. Chem. 296:100454-100454(2021).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=38388831; DOI=10.1038/s41594-024-01237-2;
RA   Hu K., Zhang Q., Chen Y., Yang J., Xia Y., Rao B., Li S., Shen Y., Cao M.,
RA   Lu H., Qin A., Jiang X.C., Yao D., Zhao J., Zhou L., Cao Y.;
RT   "Cryo-EM structure of human sphingomyelin synthase and its mechanistic
RT   implications for sphingomyelin synthesis.";
RL   Nat. Struct. Mol. Biol. 31:884-895(2024).
CC   -!- FUNCTION: Synthesizes sphingolipids through transfer of a phosphatidyl
CC       head group from a glycerophospholipid on to the primary hydroxyl of a
CC       ceramide in the lumen of the endoplasmic reticulum (PubMed:19506037,
CC       PubMed:38388831). Catalyzes the synthesis of ceramide
CC       phosphoethanolamines (CPEs) (such as N-acylsphing-4-enine 1-
CC       phosphoethanolamine) by transferring phosphoethanolamine head group,
CC       which is smaller and more hydrophilic than the phosphocholine (PC)
CC       headgroup transferred in the canonical sphingomyelin synthesis (SMS)
CC       reaction by SMS1 or SMS2, from a phosphatidylethanolamine (1,2-diacyl-
CC       sn-glycero-3-phosphoethanolamine, PE) to a ceramide (such as N-
CC       acylsphing-4-enine) (PubMed:19506037, PubMed:38388831). The larger PC
CC       prevents an efficient fit in the enzyme's catalytic pocket, leading to
CC       little or no SMS activity (PubMed:19506037, PubMed:38388831). In vitro,
CC       in the absence of ceramide, it has PLC activity with preference for
CC       phosphatidylinositol and phosphatidic acid, but also hydrolyzes
CC       phosphatidylethanolamine (PubMed:33621517, PubMed:38388831).
CC       {ECO:0000269|PubMed:19506037, ECO:0000269|PubMed:33621517,
CC       ECO:0000269|PubMed:38388831}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acylsphing-4-enine + a 1,2-diacyl-sn-glycero-3-
CC         phosphoethanolamine = an N-acylsphing-4-enine 1-phosphoethanolamine +
CC         a 1,2-diacyl-sn-glycerol; Xref=Rhea:RHEA:36079, ChEBI:CHEBI:17815,
CC         ChEBI:CHEBI:52639, ChEBI:CHEBI:64612, ChEBI:CHEBI:73203;
CC         Evidence={ECO:0000269|PubMed:38388831};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36080;
CC         Evidence={ECO:0000305|PubMed:38388831};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acylsphinganine + a 1,2-diacyl-sn-glycero-3-
CC         phosphoethanolamine = an N-acylsphinganine-1-phosphoethanolamine + a
CC         1,2-diacyl-sn-glycerol; Xref=Rhea:RHEA:42136, ChEBI:CHEBI:17815,
CC         ChEBI:CHEBI:31488, ChEBI:CHEBI:64612, ChEBI:CHEBI:78655;
CC         Evidence={ECO:0000269|PubMed:19506037};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42137;
CC         Evidence={ECO:0000305|PubMed:19506037};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-acyl-(4R)-4-hydroxysphinganine + a 1,2-diacyl-sn-glycero-
CC         3-phosphoethanolamine = an N-acyl-(4R)-4-hydroxysphinganine-1-
CC         phosphoethanolamine + a 1,2-diacyl-sn-glycerol; Xref=Rhea:RHEA:42148,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:31998, ChEBI:CHEBI:64612,
CC         ChEBI:CHEBI:78657; Evidence={ECO:0000269|PubMed:19506037};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42149;
CC         Evidence={ECO:0000305|PubMed:19506037};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-hexadecanoylsphinganine + a 1,2-diacyl-sn-glycero-3-
CC         phosphoethanolamine = N-hexadecanoyl-sphinganine-1-
CC         phosphoethanolamine + a 1,2-diacyl-sn-glycerol; Xref=Rhea:RHEA:42128,
CC         ChEBI:CHEBI:17815, ChEBI:CHEBI:64612, ChEBI:CHEBI:67042,
CC         ChEBI:CHEBI:78654; Evidence={ECO:0000269|PubMed:19506037};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42129;
CC         Evidence={ECO:0000305|PubMed:19506037};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=N-hexadecanoyl-(4R)-hydroxysphinganine + a 1,2-diacyl-sn-
CC         glycero-3-phosphoethanolamine = N-hexadecanoyl-(4R)-
CC         hydroxysphinganine-1-phosphoethanolamine + a 1,2-diacyl-sn-glycerol;
CC         Xref=Rhea:RHEA:42144, ChEBI:CHEBI:17815, ChEBI:CHEBI:64612,
CC         ChEBI:CHEBI:65107, ChEBI:CHEBI:78656;
CC         Evidence={ECO:0000269|PubMed:19506037};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42145;
CC         Evidence={ECO:0000305|PubMed:19506037};
CC   -!- PATHWAY: Sphingolipid metabolism. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:19506037}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:19506037}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96LT4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96LT4-2; Sequence=VSP_038403, VSP_038404;
CC   -!- DOMAIN: The SAM domain is required to retain SMAD8 in the endoplasmic
CC       reticulum.
CC   -!- SIMILARITY: Belongs to the sphingomyelin synthase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH80593.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK057811; BAB71586.1; -; mRNA.
DR   EMBL; AL392111; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471083; EAW54566.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54567.1; -; Genomic_DNA.
DR   EMBL; BC080593; AAH80593.1; ALT_INIT; mRNA.
DR   EMBL; BX280496; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS53543.1; -. [Q96LT4-1]
DR   CCDS; CCDS7347.1; -. [Q96LT4-2]
DR   RefSeq; NP_001167627.1; NM_001174156.2. [Q96LT4-1]
DR   RefSeq; NP_653261.1; NM_144660.3. [Q96LT4-2]
DR   RefSeq; XP_005269598.1; XM_005269541.6. [Q96LT4-1]
DR   RefSeq; XP_011537613.1; XM_011539311.1.
DR   RefSeq; XP_011537614.1; XM_011539312.4. [Q96LT4-1]
DR   RefSeq; XP_016871228.1; XM_017015739.1.
DR   RefSeq; XP_047280596.1; XM_047424640.1. [Q96LT4-1]
DR   RefSeq; XP_054220846.1; XM_054364871.1. [Q96LT4-1]
DR   RefSeq; XP_054220847.1; XM_054364872.1. [Q96LT4-1]
DR   RefSeq; XP_054220848.1; XM_054364873.1. [Q96LT4-1]
DR   PDB; 8IJQ; EM; 3.45 A; A/B/C/D/E/F=144-407.
DR   PDB; 8IJR; EM; 3.29 A; A/B/C/D/E/F=1-415.
DR   PDB; 8W9W; EM; 3.74 A; A/B/C/D/E/F=144-407.
DR   PDB; 8W9Y; EM; 3.50 A; A/B/C/D/E/F=144-407.
DR   PDBsum; 8IJQ; -.
DR   PDBsum; 8IJR; -.
DR   PDBsum; 8W9W; -.
DR   PDBsum; 8W9Y; -.
DR   AlphaFoldDB; Q96LT4; -.
DR   EMDB; EMD-35492; -.
DR   EMDB; EMD-35493; -.
DR   EMDB; EMD-37383; -.
DR   EMDB; EMD-37385; -.
DR   SMR; Q96LT4; -.
DR   BioGRID; 126778; 8.
DR   FunCoup; Q96LT4; 1580.
DR   IntAct; Q96LT4; 6.
DR   STRING; 9606.ENSP00000500411; -.
DR   SwissLipids; SLP:000000704; -.
DR   iPTMnet; Q96LT4; -.
DR   PhosphoSitePlus; Q96LT4; -.
DR   SwissPalm; Q96LT4; -.
DR   BioMuta; SAMD8; -.
DR   DMDM; 44888529; -.
DR   jPOST; Q96LT4; -.
DR   MassIVE; Q96LT4; -.
DR   PaxDb; 9606-ENSP00000438042; -.
DR   PeptideAtlas; Q96LT4; -.
DR   ProteomicsDB; 77245; -. [Q96LT4-1]
DR   ProteomicsDB; 77246; -. [Q96LT4-2]
DR   Antibodypedia; 29663; 107 antibodies from 22 providers.
DR   DNASU; 142891; -.
DR   Ensembl; ENST00000372687.4; ENSP00000361772.3; ENSG00000156671.15. [Q96LT4-2]
DR   Ensembl; ENST00000542569.6; ENSP00000438042.1; ENSG00000156671.15. [Q96LT4-1]
DR   Ensembl; ENST00000671800.1; ENSP00000500411.1; ENSG00000156671.15. [Q96LT4-1]
DR   GeneID; 142891; -.
DR   KEGG; hsa:142891; -.
DR   MANE-Select; ENST00000542569.6; ENSP00000438042.1; NM_001174156.2; NP_001167627.1.
DR   UCSC; uc001jwx.2; human. [Q96LT4-1]
DR   AGR; HGNC:26320; -.
DR   CTD; 142891; -.
DR   DisGeNET; 142891; -.
DR   GeneCards; SAMD8; -.
DR   HGNC; HGNC:26320; SAMD8.
DR   HPA; ENSG00000156671; Low tissue specificity.
DR   MIM; 611575; gene.
DR   neXtProt; NX_Q96LT4; -.
DR   OpenTargets; ENSG00000156671; -.
DR   PharmGKB; PA134868247; -.
DR   VEuPathDB; HostDB:ENSG00000156671; -.
DR   eggNOG; KOG3058; Eukaryota.
DR   GeneTree; ENSGT00940000155540; -.
DR   HOGENOM; CLU_027104_1_1_1; -.
DR   InParanoid; Q96LT4; -.
DR   OrthoDB; 422827at2759; -.
DR   PAN-GO; Q96LT4; 6 GO annotations based on evolutionary models.
DR   PhylomeDB; Q96LT4; -.
DR   TreeFam; TF314547; -.
DR   PathwayCommons; Q96LT4; -.
DR   Reactome; R-HSA-1660661; Sphingolipid de novo biosynthesis.
DR   SignaLink; Q96LT4; -.
DR   BioGRID-ORCS; 142891; 9 hits in 1155 CRISPR screens.
DR   ChiTaRS; SAMD8; human.
DR   GenomeRNAi; 142891; -.
DR   Pharos; Q96LT4; Tbio.
DR   PRO; PR:Q96LT4; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q96LT4; protein.
DR   Bgee; ENSG00000156671; Expressed in medial globus pallidus and 189 other cell types or tissues.
DR   ExpressionAtlas; Q96LT4; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB.
DR   GO; GO:0000139; C:Golgi membrane; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0047493; F:ceramide cholinephosphotransferase activity; IBA:GO_Central.
DR   GO; GO:0033188; F:sphingomyelin synthase activity; IBA:GO_Central.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:2000303; P:regulation of ceramide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006686; P:sphingomyelin biosynthetic process; NAS:UniProtKB.
DR   CDD; cd09515; SAM_SGMS1-like; 1.
DR   FunFam; 1.10.150.50:FF:000037; sphingomyelin synthase-related protein 1 isoform X1; 1.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 1.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR045221; Sphingomyelin_synth-like.
DR   InterPro; IPR025749; Sphingomyelin_synth-like_dom.
DR   PANTHER; PTHR21290:SF25; SPHINGOMYELIN SYNTHASE-RELATED PROTEIN 1; 1.
DR   PANTHER; PTHR21290; SPHINGOMYELIN SYNTHETASE; 1.
DR   Pfam; PF14360; PAP2_C; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   SMART; SM00454; SAM; 1.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Endoplasmic reticulum;
KW   Lipid metabolism; Membrane; Proteomics identification; Reference proteome;
KW   Sphingolipid metabolism; Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..415
FT                   /note="Sphingomyelin synthase-related protein 1"
FT                   /id="PRO_0000221080"
FT   TRANSMEM        153..173
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        201..221
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        232..252
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        277..297
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        322..342
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        347..367
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        368..415
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          12..78
FT                   /note="SAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   ACT_SITE        301
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        344
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        348
FT   VAR_SEQ         315..326
FT                   /note="YTPRSWNFLHTL -> CKYLFSASMRIR (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038403"
FT   VAR_SEQ         327..415
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_038404"
FT   MUTAGEN         348
FT                   /note="D->E: Abolishes CPE synthase activity."
FT                   /evidence="ECO:0000269|PubMed:19506037"
FT   HELIX           149..174
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   STRAND          176..178
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   STRAND          181..183
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   STRAND          188..190
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   TURN            191..193
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   HELIX           200..220
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   HELIX           225..249
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   TURN            255..260
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   STRAND          268..271
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   HELIX           272..280
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   TURN            281..284
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   TURN            286..289
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   HELIX           301..314
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   HELIX           323..340
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   HELIX           346..369
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   TURN            372..374
FT                   /evidence="ECO:0007829|PDB:8IJR"
FT   HELIX           386..389
FT                   /evidence="ECO:0007829|PDB:8IJR"
SQ   SEQUENCE   415 AA;  48321 MW;  AAED366F56C9CDC9 CRC64;
     MAGPNQLCIR RWTTKHVAVW LKDEGFFEYV DILCNKHRLD GITLLTLTEY DLRSPPLEIK
     VLGDIKRLML SVRKLQKIHI DVLEEMGYNS DSPMGSMTPF ISALQSTDWL CNGELSHDCD
     GPITDLNSDQ YQYMNGKNKH SVRRLDPEYW KTILSCIYVF IVFGFTSFIM VIVHERVPDM
     QTYPPLPDIF LDSVPRIPWA FAMTEVCGMI LCYIWLLVLL LHKHRSILLR RLCSLMGTVF
     LLRCFTMFVT SLSVPGQHLQ CTGKIYGSVW EKLHRAFAIW SGFGMTLTGV HTCGDYMFSG
     HTVVLTMLNF FVTEYTPRSW NFLHTLSWVL NLFGIFFILA AHEHYSIDVF IAFYITTRLF
     LYYHTLANTR AYQQSRRARI WFPMFSFFEC NVNGTVPNEY CWPFSKPAIM KRLIG
//
